These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 34357839)

  • 1. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents.
    Talamonti M; Galluzzo M
    Expert Opin Biol Ther; 2021 Nov; 21(11):1535-1537. PubMed ID: 34357839
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Psoriasis Patients with Serious Infectious Diseases.
    Megna M; Lauletta G; Tommasino N; Salsano A; Battista T; Ruggiero A; Martora F; Potestio L
    Adv Ther; 2024 Jun; 41(6):2099-2111. PubMed ID: 38709397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study.
    Kaya Ö; Keskinkaya Z; Mermutlu SI; Kılıç SO; Çakır H
    Infect Dis Clin Microbiol; 2023 Jun; 5(2):127-135. PubMed ID: 38633013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal impact of IL-17 and IL-12/23 inhibition on SARS-CoV-2/COVID-19 antibody response in psoriasis patients.
    Lavin L; Ungar B; Sa B; Guttman-Yassky E
    Arch Dermatol Res; 2023 Nov; 316(1):5. PubMed ID: 37987858
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on 'Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics'.
    Toplu SA; Altunisik N
    Clin Exp Dermatol; 2024 Mar; 49(4):394. PubMed ID: 37966357
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on published article "Exacerbation of psoriasis after post-COVID-19 vaccine reported in a young female".
    Kleebayoon A; Wiwanitkit V
    J Family Med Prim Care; 2023 Nov; 12(11):3009-3010. PubMed ID: 38186824
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and Impact of Anti-COVID-19 Vaccines in Psoriatic Patients Treated with Biologics: A Real Life Experience.
    Skroza N; Bernardini N; Tolino E; Proietti I; Mambrin A; Marchesiello A; Marraffa F; Rossi G; Volpe S; Potenza C
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.
    Wack S; Patton T; Ferris LK
    J Am Acad Dermatol; 2021 Nov; 85(5):1274-1284. PubMed ID: 34363909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.
    Sotiriou E; Tsentemeidou A; Bakirtzi K; Lallas A; Ioannides D; Vakirlis E
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e857-e859. PubMed ID: 34363647
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence.
    Piaserico S; Gisondi P; Cazzaniga S; Di Leo S; Naldi L
    J Invest Dermatol; 2022 Feb; 142(2):355-363.e7. PubMed ID: 34363826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.
    Elamin S; Hinds F; Tolland J
    Clin Exp Dermatol; 2022 Jan; 47(1):153-155. PubMed ID: 34398977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: A report of two cases.
    Bostan E; Elmas L; Yel B; Yalici-Armagan B
    Dermatol Ther; 2021 Nov; 34(6):e15110. PubMed ID: 34427024
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.
    Yalici-Armagan B; Tabak GH; Dogan-Gunaydin S; Gulseren D; Akdogan N; Atakan N
    J Cosmet Dermatol; 2021 Oct; 20(10):3098-3102. PubMed ID: 34365714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis.
    Bellinato F; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2022 Jan; 86(1):86-96. PubMed ID: 34363908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?
    Mastorino L; Dapavo P; Avallone G; Merli M; Cariti C; Rubatto M; Pala V; Quaglino P; Ribero S
    J Dermatolog Treat; 2022 Aug; 33(5):2495-2502. PubMed ID: 34409918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations.
    Waldman RA; Grant-Kels JM
    J Am Acad Dermatol; 2021 Nov; 85(5):1113-1116. PubMed ID: 34437985
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2.
    Foley P; Reich K; Blauvelt A; Bagel J; Langley RG; Miller M; Ramachandran P; Yang YW; Shen YK; You Y; Lebwohl M; Griffiths CEM
    J Drugs Dermatol; 2021 Aug; 20(8):855-860. PubMed ID: 34397205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics modulate antinuclear antibodies, immunoglobulin E, and eosinophil counts in psoriasis patients.
    Sugiura R; Terui H; Shimada-Omori R; Yamazaki E; Tsuchiyama K; Takahashi T; Aiba S; Yamasaki K
    J Dermatol; 2021 Nov; 48(11):1739-1744. PubMed ID: 34368997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case-Control Study.
    Rosenthal YS; Schwartz N; Sagy I; Pavlovsky L
    Arthritis Rheumatol; 2022 Feb; 74(2):237-243. PubMed ID: 34423909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis.
    Ali Z; Matthews R; Al-Janabi A; Warren RB
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1073-1081. PubMed ID: 34384327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.